| Amount | Holding |
|---|---|
| 2.65% | Qualys Inc |
| 2.34% | Manhattan Associates Inc |
| 2.09% | Exponent Inc |
| 2.06% | J2 Global Inc |
| 2.04% | Natera Inc |
| 2.02% | Theravance Biopharma Inc |
| 2.01% | National Research Corp Class A |
| 1.92% | BlackLine Inc |
| 1.88% | Helen Of Troy Ltd |
| 1.74% | SPX Corp |
Expense Ratio Rating
3 /10
Expense Rating
0 /10
Market Score
4 /10
Category Score
5 /10
Market Size
4 /10
Columbia Acorn USA Fund Class A
Expenses: 1.41% (Better than 0% of similar funds)
This is a bad choice for a Small Growth US Stocks fund. See why ยป
| Amount | Holding |
|---|---|
| 2.65% | Qualys Inc |
| 2.34% | Manhattan Associates Inc |
| 2.09% | Exponent Inc |
| 2.06% | J2 Global Inc |
| 2.04% | Natera Inc |
| 2.02% | Theravance Biopharma Inc |
| 2.01% | National Research Corp Class A |
| 1.92% | BlackLine Inc |
| 1.88% | Helen Of Troy Ltd |
| 1.74% | SPX Corp |
Minafi - The intersection of FI, minimalism & mindfulness.
Don't miss out on new posts, courses, interactive articles and more!
Join & Get Your First Course Free© 2025 Adam Fortuna
Site Map